John Lewis is listed as an executive officer, director, and promoter on 6 SEC Form D filings by 2 issuers between Jul 2019 and Jul 2024: Oisin Biotechnologies, Inc. (Seattle, WA — biotechnology — 2020–2024; $9.53M reported sold to 90 investors) and OncoSenX, Inc. (Seattle, WA — other technology — 2019–2021; $4.14M reported sold to 62 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 5 years. Across those companies the filings report $13.7M sold in total.
Listed alongside Gary Hudson (6 shared filings), Matthew Scholz (6 shared filings), Eric Garcia (4 shared filings), David Gobel (3 shared filings), Stephen Hilbert (2 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 6 public filings for John Lewis and found 12 differences, 1 worth asking the sponsor about: Form D filed 563 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.